Tuberculosis (TB) in pregnancy poses a substantial risk of morbidity to both the pregnant
woman and the fetus if not diagnosed and treated in a timely manner. Assessing the risk of …

Background Tuberculosis preventive therapy (TPT) reduces TB-related morbidity and
mortality in people living with HIV (PLHIV). Cascade-of-care analyses help identify gaps and …

The WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment
provides a comprehensive set of recommendations for programmatic management of …

BACKGROUND: Tuberculosis (TB) preventive therapy (TPT) decreases the risk of
developing TB disease and its associated morbidity and mortality. The aim of these clinical …

About one fourth of the world's population is estimated to be infected with M. tuberculosis (1,
2). The risk of TB disease after infection depends on several factors, the most important …

Managing pediatric tuberculosis (TB) remains a public health problem requiring urgent and
long-lasting solutions as TB is one of the top ten causes of ill health and death in children as …

Key updates ÿ A recommendation for dolutegravir (DTG)-based therapies as the preferred
first-line antiretroviral therapy (ART) option (section 11). ÿ Updated guidelines for second …

Background Isoniazid preventive therapy prevents active tuberculosis in people with HIV,
but previous studies have found no evidence of benefit in people with HIV who had a …

Background Tuberculosis (TB) preventive therapy (TPT) is an essential component of care
for people living with HIV (PLHIV). We compared efficacy, safety, completion, and drug …

BACKGROUND: Adverse effects (AE) to TB treatment cause morbidity, mortality and
treatment interruption. The aim of these clinical standards is to encourage best practise for …